VectorB2B is one of the co-promoters of the Bio-Hub Agenda – a National R&D Platform for Production, Commercialization and Distribution of Innovative Biopharmaceuticals – together with LxBio – Pharmaceuticals, TechnoPhage and Faculty of Pharmacy of the University of Lisbon.
On April 4th, 2023, the leader LxBio – Pharmaceuticals announced a new phase of the Bio-Hub mobilizing agenda through the launch of the consortium website which will allow for quick and accessible dissemination of the project.
Bio-Hub Agenda emerges as one of the first running agendas with the goal of developing and producing new biopharmaceuticals in Portugal aiming for international markets.
The Consortium has an incentive of €19M out of a total investment of €35M, which intends to see implemented by the end of 2025.
Learn more about it in the links below
www.bio-hub.pt
#PRR #construirofuturo #vectorb2b #biopharmaceuticals
Estamos a organizar a sessão científica intitulada “Como podem os CoLABs apoiar os desafios da Saúde Global?” https://lnkd.in/dnDVwafm Juntem-se a nós no próximo dia 4 de Julho, 11h30-13h30 Visitem-nos no nosso stand!
The European Pharmaceutical Association representing Small and Medium Sized Pharmaceutical Companies. Europharm’s mission is to support and defend the interests of SMEs, in order to enhance their competitiveness and entrepreneurship within the global framework of the pharmaceutical industry. Europharm SMC is a unique business network of pharmaceutical SMEs coming from all European countries who share this common goal. The […]
O Health Cluster Portugal conta com um novo Associado / The Health Cluster Portugal has a new Member: VectorB2B – Drug Development https://lnkd.in/dBafiV6N hashtag#healthclusterportugal hashtag#healthportugal
Office:
Avenida da Liberdade, 258, 6º
1250-149 Lisboa, Portugal
+351 210 976 863
© 2024 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form
